Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients

Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients

Coronavirus disease 2019 (COVID-19) caused a progress in research to find a solution to this pandemic. Also, various advances in pharmacotherapy against COVID-19 have emerged. Regarding antiviral therapy, casirivimab and imdevimab are antibodies combination against COVID-19. Standard antiviral thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Hegazy Sahar K., Tharwat Samar, Hassan Ahmed H.
Formato: Artículo
Lenguaje:English
Publicado: De Gruyter 2023-08-01
Colección:Open Medicine
Materias:
antivirals
casirivimab and imdevimab
covid-19
favipiravir
remdesivir
Acceso en línea:https://doi.org/10.1515/med-2023-0768

Ejemplares similares

Ejemplares similares